Saturday, 6 February 2021

Oxford Covid jab less effective against South African variant, study finds

University of the Witwatersrand and Oxford University research shows vaccine has reduced efficacy against mutation * Coronavirus – latest updates * See all our coronavirus coverage British drugmaker AstraZeneca said on Saturday that its vaccine developed with the University of Oxford appeared to offer only limited protection against mild disease caused by the South African variant of Covid-19, based on early data from a trial. The study from South Africa’s University of the Witwatersrand and Oxford University showed the vaccine had significantly reduced efficacy against the South African variant, according to a Financial Times report published earlier in the day. Continue reading...
http://dlvr.it/Rs9tMX
at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)

Chuka

By  Chimamanda Ngozi Adichie ,  Fiction , THE NEW YORKER  February 10, 2025 Photograph by Nakeya Brown for The New Yorker I have always long...

  • The Universal Drink
    The making—and selling—of Coca-Cola. By  E. J. Kahn, Jr. , THE NEW YORKER,  Profiles February 6, 1959 Photograph by George Marks / Retrofile...
  • The Moment Sarah Palin’s Testimony Fell Apart
    At the New York Times trial, the former governor was impressive at first. It didn’t last. BY  SETH STEVENSON  |  Slate FEB 10, 20228:31 PM S...